Compile Data Set for Download or QSAR
maximum 50k data
Found 18 with Last Name = 'vinnik' and Initial = 'a'
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Kflp Biotech

US Patent
LigandPNGBDBM314067(US9610264, Compound 4)
Affinity DataIC50:  0.270nMAssay Description:The studies began by screening for the optimal protein concentrations for the method. The studies were conducted in goat anti-mouse IgG coated black ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Kflp Biotech

US Patent
LigandPNGBDBM314059(US9610264, Compound 1)
Affinity DataIC50:  0.330nMAssay Description:The studies began by screening for the optimal protein concentrations for the method. The studies were conducted in goat anti-mouse IgG coated black ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Kflp Biotech

US Patent
LigandPNGBDBM314070(US9610264, Compound 6)
Affinity DataIC50:  0.460nMAssay Description:The studies began by screening for the optimal protein concentrations for the method. The studies were conducted in goat anti-mouse IgG coated black ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Kflp Biotech

US Patent
LigandPNGBDBM314068(US9610264, Compound 5)
Affinity DataIC50:  0.610nMAssay Description:The studies began by screening for the optimal protein concentrations for the method. The studies were conducted in goat anti-mouse IgG coated black ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Kflp Biotech

US Patent
LigandPNGBDBM314068(US9610264, Compound 5)
Affinity DataIC50:  0.640nMAssay Description:The studies began by screening for the optimal protein concentrations for the method. The studies were conducted in goat anti-mouse IgG coated black ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Kflp Biotech

US Patent
LigandPNGBDBM314065(US9610264, Compound 2)
Affinity DataIC50:  0.890nMAssay Description:The studies began by screening for the optimal protein concentrations for the method. The studies were conducted in goat anti-mouse IgG coated black ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Kflp Biotech

US Patent
LigandPNGBDBM314071(US9610264, Compound 7)
Affinity DataIC50:  0.980nMAssay Description:The studies began by screening for the optimal protein concentrations for the method. The studies were conducted in goat anti-mouse IgG coated black ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Kflp Biotech

US Patent
LigandPNGBDBM314072(US9610264, Compound 8)
Affinity DataIC50:  1.23nMAssay Description:The studies began by screening for the optimal protein concentrations for the method. The studies were conducted in goat anti-mouse IgG coated black ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Kflp Biotech

US Patent
LigandPNGBDBM314074(US9610264, Compound 9)
Affinity DataIC50:  1.53nMAssay Description:The studies began by screening for the optimal protein concentrations for the method. The studies were conducted in goat anti-mouse IgG coated black ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Kflp Biotech

US Patent
LigandPNGBDBM314075(US9610264, Compound 10)
Affinity DataIC50:  1.64nMAssay Description:The studies began by screening for the optimal protein concentrations for the method. The studies were conducted in goat anti-mouse IgG coated black ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Kflp Biotech

US Patent
LigandPNGBDBM314077(US9610264, Compound 11)
Affinity DataIC50:  2.19nMAssay Description:The studies began by screening for the optimal protein concentrations for the method. The studies were conducted in goat anti-mouse IgG coated black ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Kflp Biotech

US Patent
LigandPNGBDBM314078(US9610264, Compound 12)
Affinity DataIC50:  2.45nMAssay Description:The studies began by screening for the optimal protein concentrations for the method. The studies were conducted in goat anti-mouse IgG coated black ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Kflp Biotech

US Patent
LigandPNGBDBM314079(US9610264, Compound 14)
Affinity DataIC50:  2.64nMAssay Description:The studies began by screening for the optimal protein concentrations for the method. The studies were conducted in goat anti-mouse IgG coated black ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Kflp Biotech

US Patent
LigandPNGBDBM314080(US9610264, Compound 13)
Affinity DataIC50:  2.80nMAssay Description:The studies began by screening for the optimal protein concentrations for the method. The studies were conducted in goat anti-mouse IgG coated black ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Kflp Biotech

US Patent
LigandPNGBDBM314081(US9610264, Compound 15)
Affinity DataIC50:  4.67nMAssay Description:The studies began by screening for the optimal protein concentrations for the method. The studies were conducted in goat anti-mouse IgG coated black ...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetIntegrin alpha-4/beta-7(Homo sapiens (Human))
Kflp Biotech

US Patent
LigandPNGBDBM314066(US9610264, Compound 3)
Affinity DataIC50:  19.2nMAssay Description:The studies began by screening for the optimal protein concentrations for the method. The studies were conducted in goat anti-mouse IgG coated black ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetStructural capsid protein(Human immunodeficiency virus 1)
Drexel University College Of Medicine

Curated by ChEMBL
LigandPNGBDBM50490577(CHEMBL497058)
Affinity DataIC50:  6.00E+4nMAssay Description:Inhibition of HIV1 capsidMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetStructural capsid protein(Human immunodeficiency virus 1)
Drexel University College Of Medicine

Curated by ChEMBL
LigandPNGBDBM50490577(CHEMBL497058)
Affinity DataKd:  8.00E+5nMAssay Description:Binding affinity to HIV1 capsidMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed